The UK government's recent decision to move toward enabling human trials in which mitochondrial replacement from donor DNA would be used to treat mitochondrial disease in embryos has stirred up a predictable ethical debate. Does this step effectively green-light human germline modification, a step possibly towards even more profound human genetic engineering?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.